As of 9:50am ET
| +0.04 / +1.22%|
The 4 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents a +141.69% increase from the last price of 3.31.
The current consensus among 4 polled investment analysts is to Hold stock in aTyr Pharma Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.